Ouabain is a digitalis compound that inhibits the Na+
,K+-ATPase (NKA) activity inducing increment in cardiac force.
However, this effect seems to be dose dependent. At low concentration,
ouabain can induce an increase of NKA activity.
Methods: We investigated the effects of ouabain administration (25 mg/kg/day) for 15 days on cardiac